Feedback from The First Medical Liaison Seminar The First Medical Liaison Seminar took place on April 29-30, 2004 at the Parsippany Hilton in New Jersey. The keynote address was given by then Director of Medical Policy Development Scott Gottlieb, MD from the FDA. Topics included:

• Key Elements in Building a High Performance Medical Liaison Team
• The Legal Perspective of Medical Liaisons
• Emerging Markets
• Building the Medical Liaison/KOL Relationship
• Establishing and Integrating the Medical Liaison Role
• Disseminating Information and Responding to Questions from the Field
• TV Do’s and Don’ts for the Healthcare Professional
• Optimizing Medical Science Resources
• Creating a Thought Leader Database
• Key Business and Scientific Objectives for Medical Liaison Training Prioritization and Daily Challenges of a Medical Liaison
• From Lab to Launch Identifying Investigators and Evaluating Potential Research Sites
• Varied Backgrounds of the Medical Liaison Work-Fitness Balance
• Career Management

Some of the comments from seminar attendees

“You are awesome! I had two days of intense learning … Thanks so much for our first MSL Seminar. All who attended were rewarded with an opportunity of a lifetime. I appreciate your dedication to us in the Liaison world.”

Tracey V. Faulkner (PharmD – Wyeth Pharmaceuticals)

“The input on training will be very valuable to my new team ..... the legal and regulatory input provided useful guidance on where to position MLs within pharmaceutical companies in relation to field sales force activities ... This was an opportunity to learn how others have positioned and staffed their organizations ... I applaud your efforts ... A well-run meeting and very relevant to me.”

Anthony Magnetti, (Executive Director, Medical Liaisons - Sepracor)

“I thought the program was excellent! It was world-class from start to finish, which is highly unusual. I am unable to think of my attendance at a program that provided me with so much energy and useful take-away points.” “Learned an enormous amount - a lot that will help me with my job.” “This meeting exceeded my expectations.” “It will help me to focus some conversations with KOLs and gain their opinion about the future.”

Kristin Ryan, PharmD (Clinical Science Liaison - Yamanouchi America)

“The programming was outstanding.”

Dawn Bell, PharmD, BCPS (Director, Pharmacy Affairs - The Medicines Company)

“I’ve heard feedback from the two MSLs from our company who attended, and both felt it was a worthwhile investment. As well, I felt very validated with respect to the information and vision for MSLs that I’ve been sharing with our team.”

Fred L. Sego, Jr., RPh, JD (Associate Director, Medical Affairs - Reliant Pharmaceuticals, LLC

“I do think that the program was well done and that the turn-out for this first program was outstanding.  The format was great. The information reaffirmed what we all know. I am looking forward to next year’s program and will encourage others in the field to attend.”

Dan Womer, PhD (Group Manager - Takeda Pharmaceuticals North America)

“Congratulations on holding a timely, relevant and very needed meeting for  the medical science liaison profession.  The hiccups expected at any first meeting were not in evidence!  It was professional from start to finish.  When I saw the caliber and number of participants, I changed my schedule to attend so that I could bring my clients the most up-to-date information.  Thank you for providing this learning forum.”

Christy A. Zajack, SPHR (Vice President, Recruitment - Bench International)

“I will be able to use the information gained in defining a role that is distinct from sales ... how to clarify boundaries … all the material was good.”  

Anne Jones, DVM, MBA (Regional Director, Scientific Liaison - Yamanouchi Pharma America)

“Great job … [I got] a greater understanding of the issues and challenges faced by this group.

Marianne McGowan Nugent (Vice President - Advanced Health Media)

“I really enjoyed the different types of presentations and the varied audience. The lecture on the evolution of ML teams was great. The whole program flowed well and held my interest.”

Wilma T. Morgan, OTR/L (Occupational Therapist, Oncology - Fox Chase Cancer Center)

"Congratulations to [Scientific Advantage, LLC] for having the initiative to set-up the first Medical Liaison Seminar. I, as well as everyone I spoke with, felt the seminar was very worthwhile ... the legal and regulatory perspective continues to be of great interest to me and my colleagues. Thanks for a great seminar!"

Jennifer Laiuppa, PhD (Director Professional Relations -Watson Laboratories, Inc.)

“This validated my company’s significant training/compliance with OIG.”

Maureen R. Prather (Associate Director, BMS-NS)

“[Scientific Advantage, LCC] is to be congratulated for organizing and running a first class program, especially on the first go-around. As I think about all that goes into being a liaison, I'm excited about the possibilities for future meetings.”

Stephen B. Camper, PhD (Medical Liaison, Yamanouchi Pharma America)